• HOME
  • Search & Results
  • Full Text
  • Thesis Details
 
Page: 209
 
Full Screen

  • Title
  • DECLARATION
  • CERTIFICATE
  • Aknowledgement
  • CONTENTS
  • 1 Introduction & Review of Literature
  • INTRODUCTION
  • REVIEW OF LITERATURE
  • 1.CANCER AND FACTORS LEADING TO CANCER
  • 1.1 ROLE OF ENVIRONMENT
  • 1.1.1 Chemical and physical carcinogens.
  • 1.1.2 Estrogens and other hormones.
  • 1.1.3. Roentgen and ultraviolet radiations.
  • 1.1.4. Oncogenic Viruses.
  • 1.1.5. Parasites.
  • 1.1.6. Role of heredity.
  • 1.2 THE PROCESS OF CARCINOGENESIS
  • 1.3. REACTIVE OXYGEN SPECIES
  • 1.3.1. Reactions of free radicals in biological systems.
  • 1.3.2. Free radicals and DNA strand breaks.
  • 1.3.3. Mutations and Chromosome changes.
  • 1.3.4. Activation of xenobiotic carcinogens.
  • 1.3.5. Tumour promotion and free radicals.
  • 1.3.6. Inflammatory Responses and Reactive Oxygen Species.
  • 1.3.6.1. Cycloxygenase Products.
  • 1.3.6.2 Lipoxygenase products
  • 1.3.6.3 Antiinflammatory agents.
  • 1.3.7 Other clinical conditions related to reactive oxygen species.
  • 1.4 ANTIOXIDANTS
  • 1.5 CANCER CHEMOPREVENTION.
  • 1.5.1.1. Blocking agents
  • 1.5.2. Suppressing agents
  • 1.5.3 Chemopreventive agents of plant origin
  • 1.6 BIOLOGICAL ACTIVITIES OF TURMERIC AND CURCUMIN.
  • 1.6.1 Turmeric
  • 1.6.2. Curcumin
  • 2 Materials & Methods
  • 2.1. TEST COMPOUNDS
  • 2.1.1 Curcuminoids
  • 2.1.2 Chalcones
  • 2.2 CHEMICALS
  • 2.3. INSTRUMENTS
  • 2.4 CELL LINES
  • 2.5. ANIMALS
  • 2.6. IN VITRO CYTOTOXICITY STUDIES
  • 2.6.1 Short term -in -vitro cytotoxicity assay.
  • 2.6.2. Determination of cytotoxicity by tissue culture.
  • 2.7. LIPOSOME ENCAPSULATION
  • 2.8. DETERMINATION OF TUMOUR REDUCING ACTIVITY
  • 2.8.1. Ascites tumour model
  • 2.8.2 Solid tumour model
  • 2.9 ANTIOXIDANT STUDIES
  • 2.9.1. Superoxide scavenging activity
  • 2.9.2 Lipid peroxidation inhibiting activity
  • 2.9.3 Hydroxyl radical scavenging activity.
  • 2.9.4 Inhibition of superoxide generation in vivo.
  • 2.10. ANTIMUTAGENICITY ASSAY-AMES TEST
  • 2.10.1 Preparation of S9 fraction.
  • 2.10.2 Preparation of minimal agar plates.
  • 2.10.3 Spizizens salt solution (10X)
  • 2.10.4 Histidine / biotin solution (0.5mH)
  • 2.10.5 Ames assay procedure
  • 2.11 ANTICARCINOGENICITY TESTING
  • 2.12 ANTIINFLAMMATORY STUDIES
  • 2.13. ANTI BACTERIAL STUDIES
  • 2.14 STATISTICAL ANALYSIS
  • 3 Cytotoxic, tumour reducing and antioxidant studies of curcuminoids
  • 3.1 INTORODUCTION
  • 3.2. MATERIALS AND METHODS
  • 3.2.1. Short term -in vitro cytotoxicity of curcuminoids
  • 3.2.2. Cytotoxicity of the curcuminoids in tissue culture.
  • 3.2.3. Liposome encapasulation of curcuminoids
  • 3.2.4. Effect of curcuminoids on ascites tumour development.
  • 3.2.5. Effect of curcuminoids-on solid tumour development.
  • 3.2.6. Effect of curcuminoids on the inhibition of lipid peroxidation.
  • 3.2.7. Effect of curcuminoids on the inhibitions of superoxide production.
  • 3.2.8. Effect of curcuminoids on the inhibition of hydroxyl radical production.
  • 3.2.9. Effect of curcuminoids on the inhibition of superoxide generation by macrophages activated with PMA.
  • 3.3 RESULTS
  • 3.3.1. In vitro cytotoxic activity of curcuminoids.
  • 3.3.2. Cytotoxicity of the curcuminoids in tissue culture.
  • 3.3.3. Effect of curcuminoids on ascites tumour development
  • 3.3.4. Effect of curcuminoids on solid tumour development.
  • 3.3.5. Effect of curcuminoids on the inhibition of lipid peroxidation.
  • 3.3.6. Effect of curcuminoids on the inhibition of super oxide production.
  • 3.3.7. Effect of curcuminoids on the inhibition of hydroxyl radical production.
  • 3.3.8. Effect of curcuminoids on the inhibition of superoxide production -in -vivo.
  • 3.4. DISCUSSION
  • 4 Cytotoxic, tumour reducing and antioxidant studies of chalcones and related compounds
  • 4.1. INTRODUCTION
  • 4.2. MATERIALS AND METHODS
  • 4.2.1 Cytotoxicity of chalcones & vitro.
  • 4.2.2 Cytotoxicity of chalcones in tissue culture
  • 4.2.3 Liposome encapsulation of chalcones.
  • 4.2.4 Determination of tumour reducing activity
  • 4.2.5. Determination of lipid peroxidation inhibiting activity.
  • 4.2.6. Determination of Superoxide scavenging activity
  • 4.2.7. Determination of hydroxyl radical scavenging activity.
  • 4.2.8. Inhibition of Superoxide generation by macrophages activated with PMA
  • 4.3. RESULTS.
  • 4.3.1. Cytotoxicity of chalcones, & vitro.
  • 4.3.2. Cytotoxicity of chalcones in tissue culture
  • 4.3.3. Tumour reducing activity of the chalcones
  • 4.3.4. Effect of chalcones on the inhibition of lipid peroxidation.
  • 4.3.5. Effect of chalcones on the inhibition of superoxide production
  • 4.3.6. Effect of chalcones on the inhibition of hydroxyl radical production.
  • 4.3.7. Effect of chalcones on the inhibition of PMA induced superoxide production.
  • 4.4. DISCUSSION
  • 5 Antimutagenic and anticarcinogenic studies of curcuminoids
  • 5.1 INTRODUCTION
  • 5.2 MATERIALS AND METHODS
  • 5.3. PREPARATION OF S9 FRACTION.
  • 5.4 ANTIMUTAGENICITY ASSAY
  • 5.5 ANTICARCINOGENICITY TESTING
  • 5.6 RESULTS
  • 5.6.1 Antimutagenic Activity of Curcuminoids
  • Fig. 5.1 Papilloma formation on mouse treated with DMBA and croton oil.
  • 5.6.2 Anticarcinogenic activity of the curcuminoids.
  • DISCUSSION
  • 6 Anti-inflammatory and antibacterial studies of curcuminoids and chalcones
  • 6.1 INTRODUCTION
  • 6.2 MATERIALS AND METHODS.
  • 6.2.1 Determination of Antiinflammatory activity.
  • 6.2.2 Determination of antibacterial activity.
  • 6.3 RESULTS
  • 6.3.1 Antiinflammatory activity of natural curcuminoids.
  • 6.3.2. Antiinflammatory activity of synthetic curcuminoids.
  • 6.3.3. Antiinflammatory activity of sydnone substituted chalcones.
  • 6.3.4. Antibacterial activity of natural curcuminoids
  • 6.3.5. Antibacterial activity of synthetic curcuminoids.
  • 6.3.6. Effect of light on antibacterial activity of the curcuminoids.
  • 6.4 DISCUSSION
  • 7 Summary and Conclusion
  • APPENDIX
  • BIBILIOGRAPHY
  • List of Publications